Article
Treatment advances in systemic juvenile idiopathic arthritis
31 Mar 2014
Abstract excerpt
Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory condition that is distinct from other forms of childhood arthritis. Recently, biologic agents that specifically inhibit the cytokines interleukin (IL)-1 and IL-6 have demonstrated remarkable clinical effectiveness and confirmed the importance of these cytokines in the disease process. Future studies are likely to optimize the care of children...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
